leisure time
Previous article:
How to save PrEP access — and even expand it
Next article: CZI to create biohub to build anti
Next article: CZI to create biohub to build anti
leisure time
explore
-
Results on Novartis prostate cancer therapy could expand its use
2025-10-01 20:55 -
CRISPR pioneers react to Casgevy, first gene
2025-10-01 20:35 -
David Sabatini, ex
2025-10-01 20:31 -
Results on Novartis prostate cancer therapy could expand its use
2025-10-01 19:38 -
UnitedHealth, Optum discontinue NaviHealth name
2025-10-01 19:05 -
Readout Newsletter: The latest at Gilead, Catalent, and the NIH
2025-10-01 18:55